CL icon

Colgate-Palmolive

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 35.7%
Negative

Positive
Zacks Investment Research
3 days ago
Is Colgate Too Dependent on Pricing Actions for Revenue Growth?
CL balances pricing and volume growth as emerging markets and innovation support sales momentum.
Is Colgate Too Dependent on Pricing Actions for Revenue Growth?
Positive
The Motley Fool
3 days ago
Market Crash: The 3 Best Dividend Stocks to Buy Right Now
Some people aren't trusting this market rally, which continues to move higher. Every portfolio should have some defensive plays in it in case of a market downturn.
Market Crash: The 3 Best Dividend Stocks to Buy Right Now
Positive
The Motley Fool
7 days ago
My 5 Favorite Dividend Stocks to Buy Right Now
Consumer staples companies tend to generate resilient cash flows because their products and services remain in demand across all economic environments. The strength of Dividend Kings and long-term growers comes from structural advantages.
My 5 Favorite Dividend Stocks to Buy Right Now
Neutral
Business Wire
10 days ago
Colgate-Palmolive Webcasts Fireside Chat at the dbAccess Global Consumer Conference
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive (NYSE:CL) Chief Operating Officer, Americas, Shane Grant and Executive Vice President, M&A and Special Projects, John Faucher will participate in a fireside chat at the dbAccess Global Consumer Conference in Paris on Wednesday, June 3, 2026 at 8:45 am ET. Investors may access a live webcast of this fireside chat on Colgate's website at www.colgatepalmolive.com. For those unable to participate during the live webcast, a recorded version of the web.
Colgate-Palmolive Webcasts Fireside Chat at the dbAccess Global Consumer Conference
Positive
Zacks Investment Research
15 days ago
Why Colgate's Innovation Strategy Is Fueling Market Share Gains
CL's innovation strategy is driving market share gains as premium launches, pricing and science-based products support growth across oral care and pet nutrition.
Why Colgate's Innovation Strategy Is Fueling Market Share Gains
Positive
Barrons
15 days ago
Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch
Almost half of S&P 500 stocks are down for the year, but a bunch show signs they are reviving. Our screen spotlights the most promising.
Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch
Negative
24/7 Wall Street
16 days ago
Prediction: Colgate-Palmolive Will Jump 20% This Year
Colgate-Palmolive (NYSE:CL | CL Price Prediction) is exactly the kind of name investors hunt for when the macro picture gets murky.
Prediction: Colgate-Palmolive Will Jump 20% This Year
Positive
Zacks Investment Research
17 days ago
OLLI vs. CL: Which Stock Is the Better Value Option?
Investors interested in stocks from the Consumer Products - Staples sector have probably already heard of Ollie's Bargain Outlet (OLLI) and Colgate-Palmolive (CL). But which of these two companies is the best option for those looking for undervalued stocks?
OLLI vs. CL: Which Stock Is the Better Value Option?
Negative
Zacks Investment Research
18 days ago
Is Procter & Gamble's Baby Care Slump Dragging Overall Growth?
PG's U.S. Baby Care slump remains a weak spot, but strong global growth and targeted investments suggest it is a fixable issue, not a long-term drag.
Is Procter & Gamble's Baby Care Slump Dragging Overall Growth?
Neutral
Seeking Alpha
20 days ago
Colgate-Palmolive: Too Expensive For A Defensive Firm
Colgate-Palmolive delivered 8% sales growth in Q1 2026, but EPS declined 6%, warranting a conservative hold rating. I see organic growth of just 2.9%, with North America sales falling due to increased toothpaste competition and margin compression. FX tailwinds drove significant growth in Latin America, EMEA, and APAC, raising concerns about sustainability if currency trends reverse.
Colgate-Palmolive: Too Expensive For A Defensive Firm